Occidental Announces First Quarter 2023 Results
Get Alerts OXY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.8%
EPS Growth %: +366.7%
Join SI Premium – FREE
HOUSTON, May 09, 2023 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced its first quarter 2023 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov.
The company will hold a conference call to discuss the results on Wednesday, May 10, 2023, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10176614/f8939f3814.
A recording of the webcast will be posted on the Investor Relations section of the company’s website within several hours after the call is completed.
About Occidental
Occidental is an international energy company with assets primarily in the United States, the Middle East and North Africa. We are one of the largest oil producers in the U.S., including a leading producer in the Permian and DJ basins, and offshore Gulf of Mexico. Our midstream and marketing segment provides flow assurance and maximizes the value of our oil and gas. Our chemical subsidiary OxyChem manufactures the building blocks for life-enhancing products. Our Oxy Low Carbon Ventures subsidiary (OLCV) is advancing leading-edge technologies and business solutions that economically grow our business while reducing emissions. We are committed to using our global leadership in carbon management to advance a lower-carbon world. Visit oxy.com for more information.
Contacts
| Media | Investors |
| Eric Moses | Neil Backhouse |
| 713-497-2017 | 713-552-8811 |
| [email protected] | [email protected] |
Source: Occidental
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Middleby board approves spin-off of food processing unit Midera
- Sharplink prices $75M stock offering at 41% premium to last close
- FDA backs Entera Bio's Phase 3 trial plan for oral osteoporosis drug
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share